1. Katoh R, Kondo T, Murata S. Harmone production and secretion in thyroid tumors. Nippon Rinsho 2004;62(5):929-33.
2. Wolhllk N, Cote GJ, Bughalo MM, et al. Revelance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. J Clin Endocr Metab 1996; 81: 3740-3745.
3. Cobin RH. Medullary carcinoma of thyroid. In: Cobin RH, Sirota DK, eds. Malignant tumors of the thyroid: clinical concepts and controversies. New York Springer Verlag 1992; 112-141.
4. Aldabagh SM, Trujillo TP, Taxy JB. Occult medullary thyroid carcinoma. Unusual variant presenting with metastatic disease. Am J Clin Pathol 1986; 85(2):247-50
5. Elisei R, Bottiei V, Luchetti F et al. impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disease. J Clin Endocr Metab 2004; 89(1): 163-8.
6. Niccoli P, Wion-Barbot N, Caron P, et al (The French Medullary Study Group). Interest of routine measurement of serum calcitinin: study in a large series of thyroidectomized patients. J Clin Endocr Metab 1997; 82: 338-341.
7. Mahmood S, Bagher L, Anushiravan H et al. Diagnostic value of frozen section in thyroid nodule- surgery at the Shariati Hospital (1997-2000). Endocr Pathol 2003; 14(3): 263-268.
8. Cohen R, Campos JM, Salaun C, et al. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Clin Endocr Metab 2000; 85: 919-922.
9. Gollini P, Cataldi A, Fava C. MEN 1 and 2: the role of diagnostic imaging. Radiol Med (Torino) 2004; 107(1-2): 78-87.
10. Huang CP, Zhu YX, Tian AL. Type of surgery for 147 patients with medullary carcinoma of thyroid. Zhonghua Zhong Liu Za Zhi 2003; 25(5): 490-2.
11. Fleming JB, Lee JE, Bouvet M, et al. Surgical stategy for the treatment of medullary thyroid carcinoma. Ann Surg 1999; 230: 697-707.
12. Hamy A, Raffaitin P, Floch I et al. The importance of lymph node dissection in medullary thyroid macrocarcinoma. Ann Chir 2003; 128(7): 447-51.
13. Talpos GB, Jackson CE, Froelich JW et al. localization of residual medullary thyroid cancer by thallium/technetium Scintigraphy Surg 1985; 98: 1189-1196.
14. Castellani MR, Alessi A, Savelli G, et al. The role of nuclide therapy in medullary thyroid cancer. Tumori 2003; 89(5): 560-2.